Skip to Main Content

Paper Details

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach.
EBioMedicine
10
2022
ASF1B, BUB1B, CCNB2, RRM2, cancer, ccRCC, clear cell renal cell carcinoma, gene modules, human, human kidney cell line, patients, shRNA, target genes
Author NameAffiliation
Seishi OgawaInstitute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Karolinska Institute
Jens NielsenChalmers University of Technology, Sweden BioInnovation Institute
Jens NielsenChalmers University of Technology, Sweden BioInnovation Institute
Mathias Uhl??nKTH-Royal Institute of Technology
Mathias Uhl??nKTH-Royal Institute of Technology
Cheng ZhangKTH-Royal Institute of Technology, School of Pharmaceutical Sciences, Zhengzhou University
Adil MardinogluKTH-Royal Institute of Technology, King's College London
Adil MardinogluKTH-Royal Institute of Technology, King's College London
  • 1 - 8

Datasets

Release 1.2